Rankings
▼
Calendar
ADMA FY 2018 Earnings — ADMA Biologics, Inc. Revenue & Financial Results | Market Cap Arena
ADMA
ADMA Biologics, Inc.
$4B
FY 2018 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$17M
-25.4% YoY
Gross Profit
-$25M
-148.4% margin
Operating Income
-$60M
-354.9% margin
Net Income
-$66M
-387.1% margin
EPS (Diluted)
$-1.45
Cash Flow
Operating Cash Flow
-$63M
Free Cash Flow
-$65M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$89M
Total Liabilities
$69M
Stockholders' Equity
$20M
Cash & Equivalents
$23M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$17M
$23M
-25.4%
Gross Profit
-$25M
-$6M
-293.7%
Operating Income
-$60M
-$39M
-53.4%
Net Income
-$66M
-$44M
-50.2%
← Q4 2017
All Quarters
Q1 2018 →